- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Top Stock Picks from Analysts
U.S. Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
529
0 new
Companies which are more than 50% undervalued based on analyst price target.
529 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SMMT | US$21.08 | 10.5% | 463.6% | US$15.8b | US$33.08 | PB35.5x | E38.9% | n/a | ||
MRNA | US$35.75 | 15.6% | -58.9% | US$12.7b | US$57.32 | PS4.3x | E30.7% | n/a | ||
SRPT | US$105.35 | -3.9% | -22.6% | US$10.3b | US$181.78 | PE82.6x | E30.1% | n/a | ||
PCVX | US$82.47 | -3.5% | 14.1% | US$10.3b | US$149.89 | PB3x | E29.3% | n/a | ||
RVMD | US$41.47 | 0.05% | 42.2% | US$7.5b | US$73.29 | PS10328.1x | E20.1% | n/a | ||
LEGN | US$38.22 | 10.4% | -36.4% | US$6.7b | US$79.50 | PS13.5x | E56.5% | n/a | ||
CYTK | US$45.39 | 9.2% | -41.0% | US$5.4b | US$79.55 | PS1664.1x | E39.3% | n/a | ||
IONS | US$31.95 | 1.2% | -28.0% | US$4.9b | US$61.32 | PS6.3x | E40.9% | n/a | ||
CRSP | US$52.22 | 31.8% | -33.7% | US$4.3b | US$83.60 | PS120x | E51.1% | n/a | ||
BHVN | US$39.39 | -7.4% | -16.6% | US$4.2b | US$66.07 | PB12.6x | E28.6% | n/a | ||
RARE | US$43.62 | 0.09% | -8.9% | US$3.9b | US$90.74 | PS7.2x | E62.8% | n/a | ||
RNA | US$32.00 | -5.3% | 128.9% | US$3.9b | US$67.91 | PS377.4x | E34.3% | n/a | ||
AKRO | US$49.44 | -1.0% | 128.7% | US$3.9b | US$78.27 | PB5.1x | E16.7% | n/a | ||
ADMA | US$16.17 | 1.8% | 214.0% | US$3.8b | US$24.27 | PE56.1x | E26.7% | n/a | ||
ACLX | US$64.26 | 1.7% | 7.2% | US$3.5b | US$116.38 | PS22.3x | E22.5% | n/a | ||
IMVT | US$20.82 | 7.7% | -44.5% | US$3.5b | US$49.42 | PB10x | E9.9% | n/a | ||
APLS | US$28.18 | -1.2% | -58.5% | US$3.4b | US$46.10 | PS4.9x | E61.3% | n/a | ||
VKTX | US$29.26 | -2.3% | -18.1% | US$3.4b | US$99.29 | PB3.7x | E-4.6% | n/a | ||
CRNX | US$35.53 | 1.7% | -5.1% | US$3.3b | US$75.43 | PS3171.3x | E29.8% | n/a | ||
ZLAB | US$30.93 | 14.3% | 60.8% | US$3.2b | US$52.03 | PS9.5x | E61.7% | n/a | ||
DNLI | US$21.79 | 5.9% | 31.7% | US$3.1b | US$38.75 | PB2.4x | E29.9% | n/a | ||
FOLD | US$9.85 | 2.9% | -28.1% | US$2.9b | US$17.09 | PS6x | E53.9% | n/a | ||
MRUS | US$42.27 | 5.4% | -5.9% | US$2.8b | US$86.25 | PS80.5x | E33.0% | n/a | ||
MLTX | US$42.83 | -0.9% | -22.4% | US$2.7b | US$78.00 | PB5.5x | E37.1% | n/a |